Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Neogenomics Inc Issues Q1 2013 Guidance; Revenue Guidance Below Analysts' Estimates; Issues FY 2013 Guidance In Line With Analysts' Estimates


Thursday, 14 Feb 2013 07:02am EST 

Neogenomics Inc announced that for fiscal 2013, it expects revenue of $68 - $73 million and net income of $0.03 - $0.05 per share. For the fiscal first quarter of 2013, the Company expects revenue of $15.3 - $16.0 million and net income of $0.00 to $0.01 per share. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $70.51 million and EPS of $0.04 for fiscal 2013; revenue of $16.49 million and EPS of $0.00 for first quarter of 2013. 

Company Quote

5.19
-0.05 -0.95%
1:07pm EDT